The Effects of Empagliflozin on Arterial Wall Characteristics

Clinical trial NCT03639545 · UNKNOWN

Trial details

NCT number: NCT03639545
Sponsor: University Medical Centre Ljubljana
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Vascular Stiffness Hypoglycemic Agents Diabetes Complications Diabetes Mellitus, Type 1

Start date: 2018-03-01
Primary completion: 2018-12-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.